ProShare Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.3K | Buy |
13,869
+915
| +7% | +$3.45K | ﹤0.01% | 1988 |
|
|
2025
Q1 | $58.7K | Sell |
12,954
-3,900
| -23% | -$17.7K | ﹤0.01% | 1929 |
|
|
2024
Q4 | $119K | Buy |
16,854
+5,815
| +53% | +$41.1K | ﹤0.01% | 2037 |
|
|
2024
Q3 | $89.9K | Buy |
+11,039
| New | +$89.9K | ﹤0.01% | 1898 |
|
|
2024
Q2 | – | Sell |
-10,259
| Closed | -$77.2K | – | 1913 |
|
|
2024
Q1 | $77.2K | Buy |
+10,259
| New | +$77.2K | ﹤0.01% | 1858 |
|
|
2022
Q2 | – | Sell |
-9,802
| Closed | -$256K | – | 1938 |
|
|
2022
Q1 | $256K | Sell |
9,802
-1,615
| -14% | -$42.2K | ﹤0.01% | 1748 |
|
|
2021
Q4 | $453K | Buy |
11,417
+4,989
| +78% | +$198K | ﹤0.01% | 1530 |
|
|
2021
Q3 | $321K | Sell |
6,428
-5,170
| -45% | -$258K | ﹤0.01% | 1495 |
|
|
2021
Q2 | $644K | Buy |
11,598
+2,608
| +29% | +$145K | ﹤0.01% | 1348 |
|
|
2021
Q1 | $420K | Buy |
8,990
+1,539
| +21% | +$71.9K | ﹤0.01% | 1558 |
|
|
2020
Q4 | $324K | Buy |
+7,451
| New | +$324K | ﹤0.01% | 1559 |
|